BCKDHB
2-oxoisovalerate dehydrogenase subunit beta, mitochondrial
Also known as: ODBB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P21953
- Gene
- BCKDHB
- Ensembl
- ENSG00000083123
- Chromosome
- 6
- Canonical length
- 392 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Mitochondria
OverviewNCBI Gene
This gene encodes the E1 beta subunit of branched-chain keto acid dehydrogenase, which is a multienzyme complex associated with the inner membrane of mitochondria. This enzyme complex functions in the catabolism of branched-chain amino acids. Mutations in this gene have been associated with maple syrup urine disease (MSUD), type 1B, a disease characterized by a maple syrup odor to the urine in addition to mental and physical retardation and feeding problems. Alternative splicing at this locus results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
392 residues, UniProt reviewed canonical sequence.
>P21953|BCKDHB
1 MAVVAAAAGW LLRLRAAGAE GHWRRLPGAG LARGFLHPAA TVEDAAQRRQ VAHFTFQPDP
61 EPREYGQTQK MNLFQSVTSA LDNSLAKDPT AVIFGEDVAF GGVFRCTVGL RDKYGKDRVF
121 NTPLCEQGIV GFGIGIAVTG ATAIAEIQFA DYIFPAFDQI VNEAAKYRYR SGDLFNCGSL
181 TIRSPWGCVG HGALYHSQSP EAFFAHCPGI KVVIPRSPFQ AKGLLLSCIE DKNPCIFFEP
241 KILYRAAAEE VPIEPYNIPL SQAEVIQEGS DVTLVAWGTQ VHVIREVASM AKEKLGVSCE
301 VIDLRTIIPW DVDTICKSVI KTGRLLISHE APLTGGFASE ISSTVQEECF LNLEAPISRV
361 CGYDTPFPHI FEPFYIPDKW KCYDALRKMI NYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BCKDHB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 73 nTPM
Expression across tissuesHPA
Tissue
- liver: 73 nTPM
- kidney: 30 nTPM
- salivary gland: 25 nTPM
- colon: 21 nTPM
- breast: 21 nTPM
- rectum: 19 nTPM
Single-cell type
- bergmann glia: 487 nCPM
- pituitary stem cells: 430 nCPM
- astrocytes: 387 nCPM
- podocytes: 357 nCPM
- lacrimal acinar cells: 347 nCPM
- sertoli cells: 346 nCPM
Immune cell
- T-reg: 20 nTPM
- NK-cell: 18 nTPM
- MAIT T-cell: 13 nTPM
- plasmacytoid DC: 13 nTPM
- naive B-cell: 13 nTPM
- naive CD8 T-cell: 12 nTPM
Brain region
- white matter: 43 nTPM
- medulla oblongata: 38 nTPM
- spinal cord: 36 nTPM
- choroid plexus: 35 nTPM
- cerebellum: 35 nTPM
- midbrain: 30 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BCKDHB.
Disease | AllUniProt
Conditions BCKDHB is implicated in, by any mechanism.
- Maple syrup urine disease 1B (MSUD1B) MIM:620698
Disease | GeneticClinVar
226 pathogenic / likely-pathogenic of 855 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Maple syrup urine disease
- Maple syrup urine disease type 1B
- Maple syrup urine disease type 1A
- BCKDHB-related disorder
- Inborn genetic diseases
Disease | ImmuneIEDB
Conditions an epitope on BCKDHB was assayed in.
- systemic scleroderma B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.1
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.18
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA
- branched-chain amino acid catabolic process
- response to nutrient
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BCKDHB as an antibody target. Whether an autoantibody or antibody against BCKDHB could matter depends on whether native BCKDHB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BCKDHB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BCKDHB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...